Kitsap Respiratory Illness Report January 30 – February 5, 2022
Click here to access the latest Kitsap Respiratory Illness Report: 1.30.22 – 2.5.22.
Kitsap Provider Resources
Health Advisory: COVID-19 Updates
Actions Requested Discuss a fourth dose of COVID-19 vaccine with immunocompromised patients. The Centers for Disease Control and Prevention (CDC) recommends people ages 5 and older who are moderately or severely immunocompromised should get an additional primary shot (third dose) of an mRNA vaccine 28 days after receiving their second dose. An additional primary shot … Health Advisory: COVID-19 Updates
Kitsap Respiratory Illness Report January 23 – January 29, 2022
Click here to access the latest Kitsap Respiratory Illness Report: 1.23.22 – 1.29.22.
Health Advisory: COVID-19 Updates to Transferring Residents Between Long-Term Care and other Healthcare Settings
Actions Requested Be aware, Washington Department of Health updated the Interim Guidance for Transferring Residents between Long-Term Care and other Healthcare Settings to address health care system capacity shortages. The interim guidance, effective January 21, 2022 until February 18, 2022, waives guidance asking facilities to pause admissions with identified healthcare personnel or facility acquired COVID-19 … Health Advisory: COVID-19 Updates to Transferring Residents Between Long-Term Care and other Healthcare Settings
Kitsap Respiratory Illness Report January 9 – January 15, 2022
Click here to access the latest Kitsap Respiratory Illness Report: 1.9.22 – 1.15.22.
Kitsap Respiratory Illness Report January 2 – January 8, 2022
Click here to access latest Kitsap Respiratory Illness Report: 1.2.22 – 1.8.22.
Kitsap Respiratory Illness Report December 26, 2021 – January 1, 2022
Health Advisory: CDC updated antiviral guidance
Actions Requested Be aware, Centers for Disease Control and Prevention (CDC) updated its COVID-19 monoclonal antibody treatment recommendations. Sotrovimab monoclonal antibody formulation retains significant efficacy against Omicron, the dominant circulating variant. Other monoclonal antibody formulations under emergency use authorization (EUA)—bamlanivimab and etesevimab and casirivimab and imdevimab—lack clinical benefit against Omicron and should not be used … Health Advisory: CDC updated antiviral guidance
Kitsap Respiratory Illness Report December 19 – December 25, 2021
Click here to access the latest Kitsap Respiratory Illness Report: 12.19.21 – 12.25.21.
Health Advisory: COVID-19 Updates for Providers – New I&Q Guidance, FDA grants EUA to Molnupiravir
Actions Requested Be aware, Centers for Disease Control and Prevention (CDC) issued new isolation and quarantine (I&Q) guidance for healthcare workers (HCWs). The guidance is complex and varies based on vaccination status, level of exposure and level of crisis in the community. Carefully review the new guidance for details. Following exposure, CDC recommends: Boosted HCWs … Health Advisory: COVID-19 Updates for Providers – New I&Q Guidance, FDA grants EUA to Molnupiravir